Publications

Choksi NY, Jahnke GD, St Hilaire C, Shelby MD. 2003. Role of thyroid hormones in human and laboratory animal reproductive health. Birth Defects Res. (B) Develop Reprod Toxicol 68:479–491, DOI: 10.1210/er.2015-1106.

Guo LT, Zhang X, Kuang W, Xu H, Liu LA, Vilquin J-T, et al. (2003) Laminin a2 deficiency and muscular dystrophy; genotype-phenotype correlation in mutant mice. Neuromuscul Disord 13:207–215.

Grant RL, Rodriguez R, Hofelt CS, and Haws LC. 2002. Shortcomings in USEPA’s approach for predicting risk due to consumption of animal food products impacted by air emissions from hazardous waste combustion facilities: a case study involving phthalates. Human Ecol Risk Assess. 8(5):1137-1154.

Roberts SM, Jordan KE, Warren DA, Britt JK and James RC. 2002. Evaluation of the carcinogenicity of 1,1-Dichloroethylene (Vinylidene Chloride). Regul. Toxicol. Pharmacol. 35:44-55.

Dressman D, Araishi K, Imamura M, Sasaoka T, Liu LA, Engvall E, Hoffman EP. 2002. Delivery of a- and b-sarcoglycan by recombinant adeno- associated virus: Efficient rescue of muscle, but differential toxicity. Hum Gene Ther 13:1631–1646.

Clewell HJ, Teeguarden J, McDonald T, Sarangapani R, Lawrence G, Covington T, Gentry R, Shipp A. 2002. Review and evaluation of the potential impact of age and gender-specific pharmacokinetic differences on tissue dosimetry. Crit Rev Toxicol 32(5):329–389.

Hofelt CS, Honeycutt M, McCoy JT, and Haws LC. 2001. Development of a metabolism factor for polycyclic aromatic hydrocarbons for use in multipathway risk assessments for hazardous waste combustion facilities. Reg Toxicol Pharmacol. 33:60-65.

Gentry PR, Covington TR, Andersen ME, Clewell HJ. 2002. Application of a physiologically based pharmacokinetic model for isopropanol in the derivation of a reference dose and reference concentration. Regul Toxicol Pharmacol 36:51–68.

Strobel HW, Thompson CM, Antonovic L. 2001. Cytochromes P450 in brain: function and significance. Current Drug Metabolism. 2(2), 199–214.

Booth RG, Moniri NH, Bakker RA, Choksi NY, Nix WB, Timmerman H, Leurs R. 2002. A novel phenylaminotetralin radioligand reveals a sub-population of histamine H1 receptors. J Pharmacol Exper Therapeut 302:328–336. DOI: 10.1124/jpet.302.1.328

Bergman RL, Inzana KD, Monroe WE, Shell LG, Liu LA, Engvall E, Shelton GD. 2002. Dystrophin-deficient muscular dystrophy in a labrador retriever. J Am Anim Hosp Assoc 38:255–261.

Lea IA, Widgren EE, O’Rand MG. 2002. Analysis of recombinant mouse zona pellucida protein 2 (ZP2) constructs for immunocontraception. Vaccine 20(11–12):1515–1523.

Clewell HJ, Gentry PR, Gearhart JM, Covington TR, Banton MI, Andersen ME. 2001. Development of a physiologically based pharmacokinetic model of isopropanol and its metabolite acetone. Toxicol Sci 63:160–172.

O’Brien DP, Johnson GC, Liu L, Guo LT, Engvall E, Powell HE, Shelton GD. 2001. Laminin a 2 (merosin)-deficient muscular dystrophy and demyelinating neuropathy in two cats. J Neurol Sci 189:37–43.

Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ, Shuey DL, Cameron AM, Ellis DH, Logsdon TR, Merriman J, Setzer RW. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: Acquisition of experimental data. Toxicol Sci 59:37–48.

Setzer RW, Lau C, Mole ML, Copeland FM, Rogers JM, Kavlock RJ. 2001. Toward a biologically-based dose-response model for the developmental toxicity of 5-fluorouracil in the rat: A mathematical construct. Toxicol Sci 59:49–58.

Rogers JM, Hunter ES III. 2001. Toxicological highlight. Redox redux: A closer look at conceptual low molecular weight thiols. Toxicol Sci 62:1–3.

Huang Y-S, Held G, Andrews JE, Rogers JM. 2001. 14C-Methanol incorporation into DNA and specific proteins of organogenesis-stage mouse embryos in vitro. Reprod Toxicol 15:429–435.